CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation

Purinergic Signalling

Volumn 9, Issue 4, 2013, Pages 609-619

  Pupovac, A ^a,b   Stokes, L ^c,d   Sluyter, R ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b ILLAWARRA HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d RMIT UNIVERSITY   (Australia)

Author keywords

B cell; CD23; Monocyte; P2X7 receptor; Phospholipase D; T cell

Indexed keywords

ADENOSINE TRIPHOSPHATE; CAY10593; CAY10594; PHOSPHOLIPASE D1; PHOSPHOLIPASE INHIBITOR; PURINERGIC P2X7 RECEPTOR; UNCLASSIFIED DRUG; PHOSPHOLIPASE D; PURINERGIC P2X RECEPTOR ANTAGONIST;

ARTICLE; CHANNEL GATING; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MYELOMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOW INWARD CURRENT; DRUG EFFECTS; ENZYME ACTIVATION; EXPERIMENTAL NEOPLASM; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; NEOPLASMS, EXPERIMENTAL; PHOSPHOLIPASE D; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION;

EID: 84890568240     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-013-9371-6     Document Type: Article

References (51)

1. Sluyter R, Stokes L (2011) Significance of P2X7 receptor variants to human health and disease. Recent Pat DNA Gene Seq 5: 41-54.
2. 7 channel. Am J Physiol 275: C1224-C1231.
3. Yan Z, Khadra A, Li S, Tomic M, Sherman A et al (2010) Experimental characterization and mathematical modeling of P2X7 receptor channel gating. J Neurosci 30: 14213-14224.
4. 7 receptor. EMBO J 25: 5071-5082.
5. Marques-da-Silva C, Chaves MM, Castro NG, Coutinho-Silva R, Guimaraes MZ (2011) Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action. Br J Pharmacol 163: 912-926.
6. 7-associated uptake of large molecules involves distinct mechanisms for cations and anions in macrophages. J Cell Sci 121: 3261-3270.
7. Cankurtaran-Sayar S, Sayar K, Ugur M (2009) P2X7 receptor activates multiple selective dye-permeation pathways in RAW 264. 7 and human embryonic kidney 293 cells. Mol Pharmacol 76: 1323-1332.
8. 7R)-induced pore formation in human THP-1 cells. J Pharmacol Exp Ther 308: 1053-1061.
9. 7 receptor? Am J Physiol Cell Physiol 288: C260-271.
10. Bianco F, Perrotta C, Novellino L, Francolini M, Riganti L et al (2009) Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J 28: 1043-1054.
11. 7-associated pore or channel formation. Br J Pharmacol 147: 324-334.
12. Wang B, Sluyter R (2013) P2X7 receptor activation induces reactive oxygen species formation in erythroid cells. Purinergic Signal 9: 101-112.
13. 7 receptor function. Br J Pharmacol 149: 948-957.
14. Lenertz LY, Gavala ML, Zhu Y, Bertics PJ (2011) Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions. Immunol Res 50: 22-38.
15. Wiley JS, Sluyter R, Gu BJ, Stokes L, Fuller SJ (2011) The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78: 321-332.
16. Gu B, Bendall LJ, Wiley JS (1998) Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92: 946-951.
17. Farrell AW, Gadeock S, Pupovac A, Wang B, Jalilian I et al (2010) P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells. Biochim Biophys Acta 1800: 1173-1182.
18. 7 receptors. Int Immunol 14: 1415-1421.
19. Georgiou JG, Skarratt KK, Fuller SJ, Martin CJ, Christopherson RI et al (2005) Human epidermal and monocyte-derived Langerhans cells express functional P2X receptors. J Invest Dermatol 125: 482-490.
20. McDermott M, Wakelam MJ, Morris AJ (2004) Phospholipase D. Biochem Cell Biol 82: 225-253.
21. Gargett CE, Cornish EJ, Wiley JS (1996) Phospholipase D activation by P2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx. Biochem J 313: 529-535.
22. 7 receptor-stimulated phospholipase D activity in chronic lymphocytic leukaemia B-lymphocytes. Immunol Cell Biol 85: 68-72.
23. 7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line. J Immunol 157: 5627-5637.
24. 2z purinergic receptors in BAC1. 2F5 macrophages. Product inhibition of phospholipase D enzyme activity. J Biol Chem 268: 15571-15578.
25. Kusner DJ, Adams J (2000) ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol 164: 379-388.
26. 7-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol 167: 3300-3307.
27. 7-induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4. J Immunol 185: 3740-3749.
28. Gadeock S, Pupovac A, Sluyter V, Spildrejorde M, Sluyter R (2012) P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells. Purinergic Signal 8: 669-676.
29. Pupovac A, Foster CM, Sluyter R (2013) Human P2X7 receptor activation induces the rapid shedding of CXCL16. Biochem Biophys Res Commun 432: 626-631.
30. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL et al (2009) Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 5: 108-117.
31. 7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1β secretion. FASEB J 24: 2916-2927.
32. 7 receptor. Br J Pharmacol 153: 737-750.
33. 7 receptors, AZ11645373. Br J Pharmacol 149: 880-887.
34. 7 antagonists. J Med Chem 49: 3659-3666.
35. Min DS, Ahn BH, Jo YH (2001) Differential tyrosine phosphorylation of phospholipase D isozymes by hydrogen peroxide and the epidermal growth factor in A431 epidermoid carcinoma cells. Mol Cells 11: 369-378.
36. 7 receptor in human lymphocytes produces a delayed permeability lesion: involvement of phospholipase D. Arch Biochem Biophys 362: 197-202.
37. Morris AJ, Frohman MA, Engebrecht J (1997) Measurement of phospholipase D activity. Anal Biochem 252: 1-9.
38. Constantinescu P, Wang B, Kovacevic K, Jalilian I, Bosman GJ et al (2010) P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cells. Biochim Biophys Acta 1798: 1797-1804.
39. Le Stunff H, Raymond MN (2007) P2X7 receptor-mediated phosphatidic acid production delays ATP-induced pore opening and cytolysis of RAW 264. 7 macrophages. Cell Signal 19: 1909-1918.
40. Pelegrin P (2011) Many ways to dilate the P2X7 receptor pore. Br J Pharmacol 163: 908-911.
41. 7 receptor. Expert Opin Ther Patents 15: 271-287.
42. 2 control lysosome-mediated IL-1β secretion: Implications for inflammatory processes. Proc Natl Acad Sci U S A 101: 9745-9750.
43. 7 receptor impairs ATP-induced IL-1β release from human monocytes. J Immunol 172: 3399-3405.
44. + release. Am J Physiol Cell Physiol 286: C1100-C1108.
45. Perregaux D, Gabel CA (1994) Interleukin-1β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269: 15195-15203.
46. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L et al (1997) Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159: 1451-1458.
47. Sanz JM, Di Virgilio F (2000) Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. J Immunol 164: 4893-4898.
48. 7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am J Physiol Cell Physiol 285: C286-299.
49. Courageot MP, Lepine S, Hours M, Giraud F, Sulpice JC (2004) Involvement of sodium in early phosphatidylserine exposure and phospholipid scrambling induced by P2X7 purinoceptor activation in thymocytes. J Biol Chem 279: 21815-21823.
50. 7 receptor function. Naunyn Schmiedebergs Arch Pharmacol 359: 102-109.
51. 4- receptor-operated ion channel of human lymphocytes: inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions. Arch Biochem Biophys 292: 411-418.